[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Non-Alcoholic Steatohepatitis Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 189 pages | ID: NFC0D47A711EN
VPAResearch

US$ 700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Non-Alcoholic Steatohepatitis ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Non-Alcoholic Steatohepatitis disease clinical trials. The research work analyzes the ongoing Non-Alcoholic Steatohepatitis clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Non-Alcoholic Steatohepatitis treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Non-Alcoholic Steatohepatitis clinical trials.

Scope of the Report-
  • Ongoing Non-Alcoholic Steatohepatitis clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Non-Alcoholic Steatohepatitis
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Non-Alcoholic Steatohepatitis clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Non-Alcoholic Steatohepatitis Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Non-Alcoholic Steatohepatitis Trials by Phase
3.2 Ongoing Non-Alcoholic Steatohepatitis Trials by Type
3.3 Ongoing Non-Alcoholic Steatohepatitis Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Non-Alcoholic Steatohepatitis Trials
4.2 Top 10 Countries conducting Non-Alcoholic Steatohepatitis Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Non-Alcoholic Steatohepatitis Trials by Sponsor Type
5.2 Non-Alcoholic Steatohepatitis Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Non-Alcoholic Steatohepatitis Trials by year
6.2 Subjects Recruited for Non-Alcoholic Steatohepatitis Trials by Phase
6.3 Subjects Recruited for Non-Alcoholic Steatohepatitis Trials by Trial Type
6.4 Subjects Recruited for Non-Alcoholic Steatohepatitis Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Non-Alcoholic Steatohepatitis Trials- Phase
7.2 Ongoing Non-Alcoholic Steatohepatitis Trials- Phase
7.3 Ongoing Non-Alcoholic Steatohepatitis Trials- Phase
7.4 Ongoing Non-Alcoholic Steatohepatitis Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Non-Alcoholic Steatohepatitis- Clinical Trials by Country
Figure 2: Non-Alcoholic Steatohepatitis- Clinical Trials by Phase of Development, 2018
Figure 3: Non-Alcoholic Steatohepatitis- Clinical Trials by Status, 2018
Figure 4: Non-Alcoholic Steatohepatitis- Clinical Trials by Type, 2018
Figure 5: Non-Alcoholic Steatohepatitis- Clinical Trials Split by Region, 2000-2018
Figure 6: Non-Alcoholic Steatohepatitis- Clinical Trials by Type of Economy, 2018
Figure 7: Non-Alcoholic Steatohepatitis- Enrolment by Phase, 2018
Figure 8: Non-Alcoholic Steatohepatitis- Enrolment by Trial Type, 2018
Figure 9: Non-Alcoholic Steatohepatitis- Enrolment by Recruitment Status, 2018
Figure 10: Non-Alcoholic Steatohepatitis- Clinical Trials by Sponsor Type, 2018
Figure 11: Non-Alcoholic Steatohepatitis- Enrolment by Type of Sponsors
Figure 12: Non-Alcoholic Steatohepatitis- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Non-Alcoholic Steatohepatitis- Clinical Trials by Sponsor Type, 2018
Table 2: Non-Alcoholic Steatohepatitis- Clinical Trials by Economy Type, 2018
Table 3: Non-Alcoholic Steatohepatitis- Clinical Trials by Region, 2018
Table 4: Non-Alcoholic Steatohepatitis- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Non-Alcoholic Steatohepatitis- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Non-Alcoholic Steatohepatitis- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Non-Alcoholic Steatohepatitis- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Non-Alcoholic Steatohepatitis- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Non-Alcoholic Steatohepatitis- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications